PG
VRTX icon

PEAK6 Group’s Vertex Pharmaceuticals VRTX Stock Holding History

PEAK6 Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,094
Closed -$2.47M – 4978
2017
Q4 		$2.26M Sell
15,094
-2,785
-16% -$412K 0.01% 1302
2017
Q3 		$2.72M Sell
17,879
-1,455
-8% -$219K 0.01% 1149
2017
Q2 		$2.49M Sell
19,334
-12,364
-39% -$1.49M 0.01% 1164
2017
Q1 		$3.47M Sell
31,698
-2,969
-9% -$261K 0.03% 772
2016
Q4 		$2.55M Buy
34,667
+14,627
+73% +$1.19M 0.02% 1126
2016
Q3 		$1.75M Buy
20,040
+201
+1% +$19K 0.01% 1375
2016
Q2 		$1.71M Buy
19,839
+8,745
+79% +$756K 0.01% 1366
2016
Q1 		$882K Buy
+11,094
New +$1M 0.01% 1779
2015
Q4 		– Sell
-29,209
Closed -$3.53M – 5335
2015
Q3 		$3.04M Buy
+29,209
New +$3.75M 0.02% 1241
2014
Q1 		– Sell
-37,784
Closed -$2.99M – 5435
2013
Q4 		$2.81M Sell
37,784
-8,184
-18% -$570K 0.02% 1161
2013
Q3 		$1.74M Buy
45,968
+42,761
+1,333% +$3.4M 0.01% 1656
2013
Q2 		$257 Buy
+3,207
New +$236K ﹤0.01% 3400

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Group's VRTX Position: Q1 2018 in Review

PEAK6 Group sold out of Vertex Pharmaceuticals (VRTX) in Q1 2018, closing a stake of 15,094 shares — an estimated $2.47M sold.

PEAK6 Group first reported a position in VRTX in Q2 2013 and held it in 12 quarters. The position peaked at $3.47M in Q1 2017. 680 funds tracked by Wall St. Rank hold VRTX as of Q1 2018.

  • PEAK6 Group reported no remaining Vertex Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 15,094 Vertex Pharmaceuticals shares in Q1 2018, an estimated $2.47M.
  • PEAK6 Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • PEAK6 Group's Vertex Pharmaceuticals position peaked at $3.47M in Q1 2017.
  • 680 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.